Antiestrogens

Sep 23, 2019

Pii to Manufacture FDA-Approved Hormone Therapy Injection Drug Product

Sep 17, 2019

Mylan Expands Oncology Portfolio with Launch of Generic Faslodex® Injection, a Treatment for Advanced Breast Cancer

Oct 24, 2018

Myovant Sciences Announces Completion of Enrollment in Phase 3 HERO Trial of Relugolix in Men with Advanced Prostate Cancer

Jul 04, 2018

Forendo Pharma Initiates Phase I Study for Potential New, Targeted Treatment for Endometriosis

Apr 10, 2018

AbbVie and Neurocrine Biosciences Announce PDUFA Target Date of Q3 2018 for Elagolix in Endometriosis-Associated Pain

Mar 05, 2018

Julianne Hough Encourages Women to "Speak Up for Endo" during Endometriosis Awareness Month

Dec 08, 2017

Arvinas Presents New Data on Oral Estrogen Receptor PROTAC Degrader at 2017 San Antonio Breast Cancer Symposium

Nov 01, 2017

AbbVie Announces Positive Phase 3 Extension Study Data for Investigational Oral Treatment Elagolix for Management of Endometriosis with Associated Pain

Oct 03, 2017

Arbor Pharmaceuticals, LLC and Debiopharm International SA Announce Commercial Availability of Triptodur(TM), Triptorelin 6-month Formulation, for Treatment of Central Precocious Puberty (CPP)

Sep 06, 2017

AbbVie Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain